Buffalo.edu uses cookies to help build a better website experience for our visitors. Learn more in our Privacy Policy.
Has participated in more than 40 clinical trials and has helped bring several drugs through development to clinical use for patients with CF, focusing on inhaled antibiotics, mucoactive drugs and CFTR potentiators and correctors.